Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Atkinson

Showing results (831-840 of 1,094) with videos related to

Pageof 110
Sort By:
Biorxiv : the Preprint Server for Biology|June 25, 2024
Spatial molecular profiling of mixed invasive ductal-lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutationsOsama Shiraz Shah, Azadeh Nasrazadani, Julia Foldi, et al.
Sexual Medicine|October 28, 2025
Preliminary psychometric linguistic validation of the satisfaction survey for inflatable penile implant in SpanishJose M Flores, Bernardita M Ljubetic, Luis F Novaes, et al.
Journal of Pathology Informatics|May 20, 2021
Verification and Validation of Digital Pathology (Whole Slide Imaging) for Primary Histopathological Diagnosis: All Wales ExperienceM Babawale, A Gunavardhan, J Walker, et al.
Clinical Trials (London, England)|December 1, 2020
Composite grading algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Ethan Basch, Claus Becker, Lauren J Rogak, et al.
Eclinicalmedicine|March 10, 2023
Association of patient activity bio-profiles with health-related quality of life in patients with newly diagnosed multiple myeloma: a prospective observational cohort studyNeha Korde, Elizabet Tavitian, Donna Mastey, et al.
Pediatric Diabetes|December 6, 2003
Aberrant monocyte prostaglandin synthase 2 (PGS2) expression in type 1 diabetes before and after disease onsetS A Litherland, J X She, D Schatz, et al.
Cancer Cell|September 13, 2011
An integrated in vitro and in vivo high-throughput screen identifies treatment leads for ependymomaJennifer M Atkinson, Anang A Shelat, Angel Montero Carcaboso, et al.
Nature Communications|April 20, 2022
ESR1 mutant breast cancers show elevated basal cytokeratins and immune activationZheqi Li, Olivia McGinn, Yang Wu, et al.
Journal of the National Cancer Institute|October 1, 2014
Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)Ethan Basch, Bryce B Reeve, Sandra A Mitchell, et al.
Journal of Cancer Research and Clinical Oncology|December 7, 2016
Relationship between physician-adjudicated adverse events and patient-reported health-related quality of life in a phase II clinical trial (NCT01143402) of patients with metastatic uveal melanomaThomas M Atkinson, Jennifer L Hay, Alexander Shoushtari, et al.
Pageof 110

Showing results (831-840 of 1,094) with videos related to

Sort By:
Pageof 110
Biorxiv : the Preprint Server for Biology|June 25, 2024
Spatial molecular profiling of mixed invasive ductal-lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutationsOsama Shiraz Shah, Azadeh Nasrazadani, Julia Foldi, et al.
Sexual Medicine|October 28, 2025
Preliminary psychometric linguistic validation of the satisfaction survey for inflatable penile implant in SpanishJose M Flores, Bernardita M Ljubetic, Luis F Novaes, et al.
Journal of Pathology Informatics|May 20, 2021
Verification and Validation of Digital Pathology (Whole Slide Imaging) for Primary Histopathological Diagnosis: All Wales ExperienceM Babawale, A Gunavardhan, J Walker, et al.
Clinical Trials (London, England)|December 1, 2020
Composite grading algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Ethan Basch, Claus Becker, Lauren J Rogak, et al.
Eclinicalmedicine|March 10, 2023
Association of patient activity bio-profiles with health-related quality of life in patients with newly diagnosed multiple myeloma: a prospective observational cohort studyNeha Korde, Elizabet Tavitian, Donna Mastey, et al.
Pediatric Diabetes|December 6, 2003
Aberrant monocyte prostaglandin synthase 2 (PGS2) expression in type 1 diabetes before and after disease onsetS A Litherland, J X She, D Schatz, et al.
Cancer Cell|September 13, 2011
An integrated in vitro and in vivo high-throughput screen identifies treatment leads for ependymomaJennifer M Atkinson, Anang A Shelat, Angel Montero Carcaboso, et al.
Nature Communications|April 20, 2022
ESR1 mutant breast cancers show elevated basal cytokeratins and immune activationZheqi Li, Olivia McGinn, Yang Wu, et al.
Journal of the National Cancer Institute|October 1, 2014
Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)Ethan Basch, Bryce B Reeve, Sandra A Mitchell, et al.
Journal of Cancer Research and Clinical Oncology|December 7, 2016
Relationship between physician-adjudicated adverse events and patient-reported health-related quality of life in a phase II clinical trial (NCT01143402) of patients with metastatic uveal melanomaThomas M Atkinson, Jennifer L Hay, Alexander Shoushtari, et al.
Pageof 110